Interaction of engineered nanomaterials with the immune system: Health-related safety and possible benefits
暂无分享,去创建一个
Diana Boraschi | Paola Italiani | Benjamin J. Swartzwelter | D. Boraschi | P. Italiani | B. Swartzwelter
[1] Kevin Kendall,et al. Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles , 2013, Nanotoxicology.
[2] A. Judge,et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Max Costa,et al. Genetic and Epigenetic Effects of Nanoparticles , 2013 .
[4] Diana Boraschi,et al. Modulation of Macrophage Activation , 2016 .
[5] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[6] T. Ishida,et al. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[7] Diana Boraschi,et al. Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True , 2017, Front. Immunol..
[8] Luca Costantino,et al. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. , 2012, Nanomedicine.
[9] J. McKearn,et al. Biochemical and Immunological Properties of Cytokines Conjugated to Dendritic Polymers , 2004, Biomedical microdevices.
[10] Marina A Dobrovolskaia,et al. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[11] Albert Duschl,et al. Nanoparticles and Allergy , 2014 .
[12] F M Muggia,et al. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[14] Paolo Decuzzi,et al. Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] D. Fischer,et al. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] Wei Zhao,et al. References Subscriptions Permissions Email Alerts Fullerene Nanomaterials Inhibit the Allergic Response , 2013 .
[17] Lucia Migliore,et al. Epigenetic effects of nano-sized materials. , 2013, Toxicology.
[18] David Leong,et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.
[19] A. Casset,et al. Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. , 2013, Toxicology letters.
[20] M. Pallardy,et al. Why the Immune System Should Be Concerned by Nanomaterials? , 2017, Front. Immunol..
[21] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[22] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[23] M. Netea,et al. Adaptive Characteristics of Innate Immune Responses in Macrophages. , 2016, Microbiology spectrum.
[24] D. Josephs,et al. Tumour-associated macrophage polarisation and re-education with immunotherapy. , 2015, Frontiers in bioscience.
[25] Michaela Kendall,et al. Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles , 2015, Nanotoxicology.
[26] Marina A Dobrovolskaia,et al. Choice of method for endotoxin detection depends on nanoformulation. , 2014, Nanomedicine.
[27] Abhinav Kumar,et al. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[28] P Couvreur,et al. In vitro evaluation of nanoparticles spleen capture. , 1999, Life sciences.
[29] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[30] John Samuel,et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[31] Bengt Fadeel,et al. Extracellular entrapment and degradation of single-walled carbon nanotubes. , 2014, Nanoscale.
[32] Bengt Fadeel,et al. It takes two to tango: Understanding the interactions between engineered nanomaterials and the immune system. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[33] Judith Klein-Seetharaman,et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.
[34] Mauro Ferrari,et al. Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.
[35] Russell J Mumper,et al. Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. , 2004, Vaccine.
[36] Jean-Christophe Leroux,et al. Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. , 2009, Biomacromolecules.
[37] John Samuel,et al. Biodegradable nanoparticle delivery of a Th2‐biased peptide for induction of Th1 immune responses , 2006, The Journal of pharmacy and pharmacology.
[38] Elisa Boutet-Robinet,et al. Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon , 2017, Scientific Reports.
[39] Biana Godin,et al. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel , 2017, Front. Immunol..
[40] S. Krämer,et al. Particle size and activation threshold: a new dimension of danger signaling. , 2010, Blood.
[41] Denis Girard,et al. Silver nanoparticles rapidly induce atypical human neutrophil cell death by a process involving inflammatory caspases and reactive oxygen species and induce neutrophil extracellular traps release upon cell adhesion. , 2015, International immunopharmacology.
[42] Diana Boraschi,et al. The Gracefully Aging Immune System , 2013, Science Translational Medicine.
[43] Janos Szebeni,et al. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. , 2014, Molecular immunology.
[44] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[45] J. Tschopp,et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β , 2010, Proceedings of the National Academy of Sciences.
[46] Bengt Fadeel,et al. Nanoparticles and innate immunity: new perspectives on host defence. , 2017, Seminars in immunology.
[47] Bengt Fadeel,et al. Clear and present danger? Engineered nanoparticles and the immune system. , 2012, Swiss medical weekly.
[48] N. Sheikh,et al. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses. , 1999, Vaccine.
[49] Matthew Boyles,et al. Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses , 2015, Particle and Fibre Toxicology.
[50] H. Krug,et al. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. , 2007, Toxicology letters.
[51] G. Ott,et al. Development of Vaccine Adjuvants: A Historical Perspective , 2006 .
[52] Bengt Fadeel,et al. Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice , 2012, PloS one.
[53] Richard A Flavell,et al. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.
[54] T. Miyakawa,et al. Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .
[55] H. Merkle,et al. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[56] M. Fraga,et al. The effect of exposure to nanoparticles and nanomaterials on the mammalian epigenome , 2016, International journal of nanomedicine.
[57] Per Axel Clausen,et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. , 2011, ACS nano.
[58] P. Petersen,et al. Endotoxins-the invisible companion in biomaterials research. , 2013, Tissue engineering. Part B, Reviews.
[59] Albert Duschl,et al. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects , 2011, Particle and Fibre Toxicology.
[60] Jürgen Groll,et al. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. , 2010, Nano letters.
[61] John D. Lambris,et al. Protection of Nonself Surfaces from Complement Attack by Factor H-Binding Peptides: Implications for Therapeutic Medicine , 2011, The Journal of Immunology.
[62] Chi-Feng Hung,et al. The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs). , 2015, Chemico-biological interactions.
[63] I. Bellinghausen,et al. Recent advances in the use of nanoparticles for allergen‐specific immunotherapy , 2017, Allergy.
[64] Alberto Mantovani,et al. Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.
[65] Diana Boraschi,et al. Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles , 2015, Nanotoxicology.
[66] Miklós Tóth,et al. Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles , 2007, Journal of liposome research.
[67] R. Xavier,et al. Trained immunity: A program of innate immune memory in health and disease , 2016, Science.
[68] Zhenzhen Shi,et al. Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation , 2017, Nanotoxicology.
[69] Scott E McNeil,et al. Nanotechnology safety concerns revisited. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[70] B. Erlanger,et al. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[71] Diana Boraschi,et al. From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology , 2015, Vaccines.
[72] Marina A Dobrovolskaia,et al. Evaluation of nanoparticle immunotoxicity. , 2009, Nature nanotechnology.
[73] Judith Klein-Seetharaman,et al. Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase. , 2013, Small.
[74] E. Latz,et al. Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.